Condition (MeSH)
Fournier Gangrene
ClinicalTrials.gov lists 15 trials for Fournier Gangrene or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
15 of the 15 trials are tagged with Fournier Gangrene itself; the rest are tagged with a narrower condition beneath it.
When did Fournier Gangrene trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 2 |
| 2017 | 1 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 3 |
| 2010 | 1 |
| 2005 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 15 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Fournier Gangrene trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
| Not applicable | 1 |
| Observational | 12 |
How many Fournier Gangrene trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |
| Completed | 11 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Fournier Gangrene trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Atox Bio Ltd | 1 |
| Integra LifeSciences Corporation | 1 |
| Istanbul Training and Research Hospital | 1 |
| National Health Service, United Kingdom | 1 |
Which drugs are being tested for Fournier Gangrene? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Daptomycin | 1 |
Interventions as named in the registry (5)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| NaCl 0.9% NS | 1 |
| Hyperbaric Oxygen | 1 |
| AB103 0.5 mg/kg | 1 |
| IVIG | 1 |
| No Intervention: Observational Cohort | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Fournier Gangrene trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cardiac arrest | 8 | 1 |
| Acute kidney injury | 6 | 1 |
| Acute respiratory distress syndrome | 6 | 1 |
| Necrotizing soft tissue infection | 6 | 1 |
| Acute myocardial infarction | 5 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Fournier Gangrene? (3)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| A fatal case of Fournier's gangrene during neoadjuvant radiotherapy for rectal cancer. | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] | 2019 | Yes |
| Fournier's gangrene. A clinical review. | Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica | 2016 | Yes |
| Safety of Sodium-Glucose Co-Transporter 2 Inhibitors. | The American journal of cardiology | 2019 | No |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.